Clinical Trial Update: Study Of Single Ascending Doses Of PBL 1427 In Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 single ascending dose study of the investigational drug PBL 1427 in healthy volunteers, sponsored by Panacea Biotec, associated with diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• PBL 1427 (PBL 1427)

Snippet

Sponsor: Panacea Biotec Ltd | Conditions: Diabetes Mellitus | Phase 1 | Status: UNKNOWN